IP Verse

Solid Oral Formulation Of Fenretinide

Patent No. EP3171860 (titled "Solid Oral Formulation Of Fenretinide") was filed by Laurent Pharmaceuticals on Jul 24, 2015. The application was issued on Dec 11, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WUESTHOFF & WUESTHOFFSep 9, 2025SONNENHAUSER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3171860

LAURENT PHARMACEUTICALS
Application Number
EP15825528A
Filing Date
Jul 24, 2015
Status
Granted And Under Opposition
Nov 8, 2024
Publication Date
Dec 11, 2024
External Links
Slate, Register , Google Patents